Wang, Lu
Li, Shuangshuang
Luo, Huanhua
Lu, Qi
Yu, Shuwen
Funding for this research was provided by:
National Natural Science Foundation of China (81803570)
Postdoctoral Science Foundation of China (2019M652411)
Jinan Science and Technology Bureau (202134050)
Article History
Received: 4 May 2022
Accepted: 25 August 2022
First Online: 14 October 2022
Declarations
:
: The study protocol was approved by Shanghai Qut do Biotech Company Ethics Committee (SHYJS-CP-1501006). All experiments were performed in compliance with the relevant regulations, and all patients provided written informed consent. Besides, the animal studies were approved by the Animal Ethics Committee of Central Hospital Affiliated to Shandong First Medical University (JNCH2021-79).. The experiments followed the Guidelines for the Care and Use of Laboratory Animals issued by the Chinese Council on Animal Research.
: All the authors agree to the content of the paper.
: The authors declare no competing interests.